To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Assessing efficacy of IA injection of LWM fraction of 5% human serum albumin in treatment of knee OA

Download
Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
July 2019

Assessing efficacy of IA injection of LWM fraction of 5% human serum albumin in treatment of knee OA

Vol: 8| Issue: 7| Number:34| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:N/A
Journal Level of Evidence:N/A

Preliminary Trial of Intra-articular LMWF-5A for Osteoarthritis of the Knee

Orthopedics. 2017 Jan 1;40(1):e49-e53. doi: 10.3928/01477447-20160926-02

Contributing Authors:
KM Salottolo J Schwappach Sm Dryden

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

40 patients with knee osteoarthritis were randomized to three bi-weekly injections of either the low molecular weight fraction of 5% human serum albumin (LMWF-5A) or placebo. Patients were assessed for outcome related to the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) and incidence of adverse events. Reduction in WOMAC pain scores from 2 weeks to 12 weeks did not demonst...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

The OE High Impact metric uses AI to determine the impact a study will have by considering the content of the article itself. Built using the latest advances of natural language processing techniques. OE High Impact predicts an article’s future number of citations than impact factor alone.

Continue